695 filings
ARS
2023 FY
AKBA
Akebia Therapeutics Inc.
25 Apr 24
Annual report to shareholders
5:19pm
DEFA14A
AKBA
Akebia Therapeutics Inc.
25 Apr 24
Additional proxy soliciting materials
5:18pm
DEF 14A
AKBA
Akebia Therapeutics Inc.
Definitive proxy
25 Apr 24
5:17pm
8-K
AKBA
Akebia Therapeutics Inc.
23 Apr 24
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
8:32am
8-K
AKBA
Akebia Therapeutics Inc.
16 Apr 24
Entry into a Material Definitive Agreement
7:33am
8-K
ogkocgdyczn
27 Mar 24
Akebia Receives FDA Approval of Vafseo® (vadadustat) Tablets for the Treatment of Anemia due to Chronic Kidney Disease in Adult Patients on Dialysis
8:35pm
8-K
7qoo861uro
15 Mar 24
Departure of Directors or Certain Officers
4:05pm
8-K
po23v13xvr7 z4u1evg
14 Mar 24
Akebia Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
4:18pm
4
l296gsanbp pi3zguzl4
1 Mar 24
Akebia Therapeutics / Michel Dahan ownership change
5:49pm
4
vhmlq
1 Mar 24
Akebia Therapeutics / Nicole R. Hadas ownership change
5:48pm
4
t3gn8hm
1 Mar 24
Akebia Therapeutics / John P. Butler ownership change
5:47pm
4
3iun3brh0ld05
1 Mar 24
Akebia Therapeutics / Steven Keith Burke ownership change
5:46pm
4
vxdahfple0 t69n
29 Feb 24
Akebia Therapeutics / Nicole R. Hadas ownership change
6:03pm
4
af3sso5d3
29 Feb 24
Akebia Therapeutics / Michel Dahan ownership change
6:02pm
4
yja9ojhrsx8cw3x42238
29 Feb 24
Akebia Therapeutics / Steven Keith Burke ownership change
6:01pm
4
hhqi9u28gcb
29 Feb 24
Akebia Therapeutics / John P. Butler ownership change
6:00pm
144
fucdlfs bbbssj
29 Feb 24
Notice of proposed sale of securities
4:32pm
144
j6fhu7gkf
29 Feb 24
Notice of proposed sale of securities
4:30pm
144
lpu5jw0k
29 Feb 24
Notice of proposed sale of securities
4:28pm